Cargando…
Correction to: Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825320/ https://www.ncbi.nlm.nih.gov/pubmed/29177802 http://dx.doi.org/10.1007/s13555-017-0215-0 |
| _version_ | 1783302171164409856 |
|---|---|
| author | Dattola, Annunziata Cannizzaro, Maria Vittoria Mazzeo, Mauro Bianchi, Luca |
| author_facet | Dattola, Annunziata Cannizzaro, Maria Vittoria Mazzeo, Mauro Bianchi, Luca |
| author_sort | Dattola, Annunziata |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5825320 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58253202018-02-28 Correction to: Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data Dattola, Annunziata Cannizzaro, Maria Vittoria Mazzeo, Mauro Bianchi, Luca Dermatol Ther (Heidelb) Correction Springer Healthcare 2017-11-25 /pmc/articles/PMC5825320/ /pubmed/29177802 http://dx.doi.org/10.1007/s13555-017-0215-0 Text en © The Author(s) 2017 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Correction Dattola, Annunziata Cannizzaro, Maria Vittoria Mazzeo, Mauro Bianchi, Luca Correction to: Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data |
| title | Correction to: Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data |
| title_full | Correction to: Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data |
| title_fullStr | Correction to: Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data |
| title_full_unstemmed | Correction to: Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data |
| title_short | Correction to: Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data |
| title_sort | correction to: certolizumab pegol in the treatment of psoriasis and psoriatic arthritis: preliminary real-life data |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825320/ https://www.ncbi.nlm.nih.gov/pubmed/29177802 http://dx.doi.org/10.1007/s13555-017-0215-0 |
| work_keys_str_mv | AT dattolaannunziata correctiontocertolizumabpegolinthetreatmentofpsoriasisandpsoriaticarthritispreliminaryreallifedata AT cannizzaromariavittoria correctiontocertolizumabpegolinthetreatmentofpsoriasisandpsoriaticarthritispreliminaryreallifedata AT mazzeomauro correctiontocertolizumabpegolinthetreatmentofpsoriasisandpsoriaticarthritispreliminaryreallifedata AT bianchiluca correctiontocertolizumabpegolinthetreatmentofpsoriasisandpsoriaticarthritispreliminaryreallifedata |